Actively Recruiting

All Genders
NCT05740696

Registry Study for Optimal Management of Liver Failure in the Chinese Population

Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2023-02-23

500

Participants Needed

14

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Liver failure is the most severe form of liver damage caused by viral, alcoholic, drug-related and ischemia-reperfusion factors, often combined with extrahepatic organ damage, resulting in a high mortality rate. This study intends to construct a real-world case registry database of inpatients with liver failure based on an electronic clinical data collection system through a multicenter collaborative network to study the clinical characteristics, epidemiology of bacterial and fungal infections, the impact of sarcopenia on clinical prognosis, and optimization of treatment strategies such as antiviral and artificial liver in Chinese inpatients with liver failure. The cohort and experience generated from this study will be used as a support for a series of future studies to focus on clinical issues such as infection, end-stage liver disease combined with organ failure, and early warning of critically ill patients.

CONDITIONS

Official Title

Registry Study for Optimal Management of Liver Failure in the Chinese Population

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis consistent with liver failure or pre-liver failure
  • Extreme weakness with significant gastrointestinal symptoms such as anorexia, vomiting, and abdominal distention
  • Elevated alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) with progressive jaundice (total bilirubin ≥85.5 µmol/L)
  • Bleeding tendency with prothrombin activity ≤60% or INR ≥1.5
Not Eligible

You will not qualify if you...

  • Any event or complication that significantly affects the assessment of clinical status according to the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 14 locations

1

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China, 710061

Actively Recruiting

2

Ankang Central Hospital

Ankang, China

Actively Recruiting

3

Xiangya Hospital of Central South University

Changsha, China

Not Yet Recruiting

4

Hanzhong 3201 Hospital

Hanzhong, China

Not Yet Recruiting

5

Qilu Hospital of Shandong University

Jinan, China

Not Yet Recruiting

6

First Hospital of Lanzhou University

Lanzhou, China

Not Yet Recruiting

7

Weinan Central Hospital

Weinan, China

Not Yet Recruiting

8

Air Force Medical University Tangdu Hospital

Xi'an, China

Not Yet Recruiting

9

Shaanxi provincial people's hospital

Xi'an, China

Not Yet Recruiting

10

The Second Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China

Actively Recruiting

11

Xi 'an International Medical Center Hospital

Xi'an, China

Not Yet Recruiting

12

Xianyang Central Hospital

Xianyang, China

Actively Recruiting

13

The Affiliated Hospital of Yan'an University

Yanan, China

Not Yet Recruiting

14

General Hospital of Ningxia Medical University

Yinchuan, China

Not Yet Recruiting

Loading map...

Research Team

Y

Yingli He, Pro.

CONTACT

J

Juan Li, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here